Perception of Quality of Life in Patients Undergoing Endoscopic Vertical Gastroplasty
SATIBAR
1 other identifier
interventional
20
1 country
1
Brief Summary
An emerging alternative to bariatric surgery for the treatment of obesity is bariatric endoscopic gastroplasty (gve), which offers a less invasive approach with fewer complications. however, the weight loss achieved through this technique is generally lower than that achieved with traditional bariatric surgery, leaving the impact on patients' quality of life uncertain. the aim of this multicentre exploratory descriptive study is to investigate the perception of the quality of life of patients with obesity undergoing gve, conducted at the complex operative unit of surgical digestive endoscopy of the university policlinico Agostino Gemelli IRCCS foundation as the promoting centre. italian patients over 18 years old, in post-gve follow-up for at least six months, with access to and familiarity with a computer or tablet will be included. data will be collected via a single semi-structured interview on microsoft teams, audio recorded and transcribed in full, and analysed using nvivo v1.6.2.32. participants' statements will be categorised into semantic categories and subsequently refined into sub-themes and themes through an iterative process.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Mar 2025
Typical duration for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedStudy Start
First participant enrolled
March 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
April 1, 2026
March 1, 2026
1.9 years
February 17, 2025
March 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The perception of quality of life will be investigated through specific questions
The perception of quality of life will be investigated through specific questions regarding: general well-being and satisfaction with different aspects of daily life, including personal satisfaction and perception of one's own body after the procedure, allowing participants to freely express their perceptions, concerns and wishes regarding their post-operative experience after GVE. Overall satisfaction with the GVE procedure.
From treatment with GVE to ineterview. At least six months
Secondary Outcomes (1)
Analysis of positive and negative experiences post-GVE
From treatment with GVE to ineterview. At least six months
Study Arms (1)
Patients who have undergone endoscopic vertical gastroplasty
EXPERIMENTALPatients who have undergone endoscopic vertical gastroplasty and who are interviewed in a semi-structured interview regarding their quality of life 6 months after surgery.
Interventions
Data will be collected through a single semi-structured interview conducted by the principal investigators at each participating centre. A comprehensive review of the literature will be carried out to formulate the guiding questions for the interviews. The face-to-face interviews, conducted via the Microsoft Teams platform, will be flexible in order to prioritise patients' unique perspectives and explore all areas of research in depth.
Eligibility Criteria
You may qualify if:
- Age: Patients older than 18 years.
- Treatment: Patients who have undergone GVE surgery and have been in post- surgery for at least six months.
- Access and technological competence: Patients who have a computer or tablet at home and are familiar with their use.
- Informed consent: Patients who are able to understand and give informed consent informed consent to participate in the study.
- Language comprehension: Patients who have a good understanding of the language Italian language, both written and spoken, to ensure correct completion and understanding of the informed consent and the study instructions.
You may not qualify if:
- Patients who have been enrolled in experimental studies involving additional procedures during GVE will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universitario Agostino Gemelli
Roma, RM, 00168, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chiara Massari
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research nurse
Study Record Dates
First Submitted
February 17, 2025
First Posted
February 21, 2025
Study Start
March 28, 2025
Primary Completion (Estimated)
February 18, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
April 1, 2026
Record last verified: 2026-03